Prognostic Impact of Acute Beta-Blocker Therapy on Top of Aspirin and Angiotensin-Converting Enzyme Inhibitor Therapy in Consecutive Patients With ST-Elevation Acute Myocardial Infarction

American Journal of Cardiology

Volumn 99, Issue 9, 2007, Pages 1208-1211

  Wienbergen, Harm ^a   Zeymer, Uwe ^a   Gitt, Anselm Kai ^a   Juenger, Claus ^a   Schiele, Rudolf ^a   Heer, Tobias ^a   Towae, Frank ^a   Senges, Jochen ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOGENIC SHOCK; CLINICAL PRACTICE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENDER; GROUPS BY AGE; HEART RATE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; UNIVARIATE ANALYSIS;

ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; DRUG THERAPY, COMBINATION; FEMALE; FIBRINOLYTIC AGENTS; GERMANY; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; REGISTRIES; TREATMENT OUTCOME;

EID: 34247542580     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.12.036     Document Type: Article

References (14)

1. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol 44 (2004) 671-719
2. Yusuf S., Lessem J., Jha P., and Lonn E. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials. J Hypertens 11 suppl (1993) S61-S73
3. First International Study of Infarct Survival Collaborative Group. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet 2 (1986) 57-66
4. Harjai K.J., Stone G.W., Boura J., Grines L., Garcia E., Brodie B., Cox D., O'Neill W.W., and Grines C. Effects of prior beta-blocker therapy on clinical outcomes after primary coronary angioplasty for acute myocardial infarction. Am J Cardiol 91 (2003) 655-660
5. Pfisterer M., Cox J.L., Granger C.B., Brener S.J., Naylor C.D., Califf R.M., van de Werf F., Stebbins A.L., Lee K.L., Topol E.J., and Armstrong P.W. Atenolol use and clinical outcomes after thrombolysis for acute myocardial infarction: the GUSTO-I experience. Global Utilization of Streptokinase and TPA (alteplase) for Occluded Coronary Arteries. J Am Coll Cardiol 32 (1998) 634-640
6. Freemantle N., Cleland J., Young P., Mason J., and Harrison J. β-Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 318 (1999) 1730-1737
7. Second Chinese Cardiac Study (CCS-2) Collaborative Group. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. J Cardiovasc Risk 7 (2000) 435-441
8. COMMIT (Clopidogrel and Metoprolol In Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366 (2005) 1622-1632
9. Rustige J., Schiele R., Burczyk U., Koch A., Gottwik M., Neuhaus K.L., Tebbe U., Uebis R., and Senges J. The 60 minutes myocardial infarction project. Treatment and clinical outcome of patients with acute myocardial infarction in Germany. Eur Heart J 18 (1997) 1438-1446
10. Schuster S., Koch A., Burczyk U., Schiele R., Wagner S., Zahn R., Glunz H.G., Heinrich F., Stuby K., Berg G., et al., MITRA Study Group. Therapy of acute myocardial infarction, impact of clinical trials on clinical practice: the MITRA pilot phase. Z Kardiol 86 (1997) 273-283
11. Wagner S., Schneider S., Schiele R., Fischer F., Dehn H., Grube R., Becker G., Baumgärtel B., Altmann E., and Senges J. Acute myocardial infarction in Germany between 1996 and 1998; therapy and intrahospital course: results of the Myocardial Infarction Registry (MIR) in Germany. Z Kardiol 88 (1999) 857-867
12. Wienbergen H., Gitt A.K., Schiele R., Juenger C., Heer T., Gottwik M., Manthey J., Hempel A., Bestehorn K., Senges J., and Rauch B. Actual clinical practice of exercise testing in consecutive patients after non-ST-elevation myocardial infarction: results of the Acute Coronary Syndromes Registry. Eur J Cardiovasc Prev Rehabil 13 (2006) 457-463
13. Morrow D.A., Antman E.M., Charlesworth A., Cairns R., Murphy S.A., de Lemos J.A., Giugliano R.P., McCabe C.H., and Braunwald E. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation. Circulation 102 (2000) 2031-2037
14. Owen A. Intravenous beta-blockade in acute myocardial infarction. Should be used in combination with thrombolysis. BMJ 317 (1998) 226-227